Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2007-03-13
2007-03-13
Woodward, Michael P. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S439000
Reexamination Certificate
active
10303117
ABSTRACT:
A method for making the potassium, sodium and other hygroscopic salts of (−)-hydroxycitric acid and mixtures thereof workable by initial treatment with a desiccating agent, such as fumed silicon dioxide. These may be further rendered non-hygroscopic and non-reactive in acidic media via subsequent encasement in hydrophobic and acidophobic polymers. The calcium and magnesium salts of (−)-hydroxycitric acid likewise can be rendered nonreactive in acidic media. The resulting products are suitable for tableting, encapsulation and use in other dry media for weight loss, appetite suppression, improvements in fat metabolism and postprandial lipemia and other pharmaceutical purposes. Further, the products of this invention can be made nonreactive as components of acidic liquid drink mixes and snack bars and can be used in the production of controlled release administration formats.
REFERENCES:
patent: 3764692 (1973-10-01), Lowenstein
patent: 4609675 (1986-09-01), Franz
patent: 4910023 (1990-03-01), Botzolakis et al.
patent: 5225197 (1993-07-01), Bolt et al.
patent: 5536516 (1996-07-01), Moffett et al.
patent: 5626849 (1997-05-01), Hastings et al.
patent: 5656314 (1997-08-01), Moffett et al.
patent: 5783603 (1998-07-01), Majeed et al.
patent: 5914326 (1999-06-01), McCarty et al.
patent: 6160172 (2000-12-01), Balasubramanyam et al.
patent: 6207714 (2001-03-01), Clouatre et al.
patent: 6221901 (2001-04-01), Shrivastava et al.
patent: 6395296 (2002-05-01), Balasubramanyam et al.
patent: 6447807 (2002-09-01), Clouatre et al.
Dallas L. Clouatre, et al. Method For Stable And Controlled Delivery Of (—)-Hydroxycitric Acid Nov. 23, 2002.
Clouatre, Dallas and Michael E. Rosenbaum.The Diet and Health Benefits of HCA(Hydroxicitric Acid). (Keats Publshing, New Canaan, CT: 1994).
Drury, Heber. “Garcinia cambogia” inThe Useful Plants Of India, 2nd Edition. (William H. Allen and Co., London: 1873) p. 220.
Heymsfield, Steven B, et al.Garcinia cambogia(hydroxycitric acid) as a potential antiobesity agent: a randomized control trial. JAMA. Nov. 11, 1998;280(18):1596-1600.; also, especially, Letters, JAMA 1999:282-235.
Ishihara K, Oyaizu S, Onuki K, Lim K, Fushiki T. Chronic (—)-hydroxycitrate administration spares carbohydrate utilization and promotes lipid oxidation during exercise in mice. J Nutr. Dec. 2000;130(12):2990-5.
Lewis, YS, Neelakantan S. (—)-Hydroxycitric acid—the principal acid in the fruits ofGarcinia cambogiaDesr. Phytochemistry 1965;4:619-625.
Lewis YS. Isolation and properties of hydroxycitric acid. In John M. Lowenstein, ed., vol. 13 in Methods in Enzymology,Citric Acid Cycle(New York: Academic Press, 1969) 613-619.
Loe Y, Bergeron N, et al. Time Course of Hydroxycitrate Clearance in Fasting and Fed Humans. FASEB Journal 15;4:632, Abs. 501.1, 2001.
Loe YC, Bergeron N, et al. Gas chromatography/mass spectrometry method to quantify blood hydroxycitrate concentration. Anal Biochem. May 1, 2001;292(1):148-54.
Publications & Information Directorate, Council of Scientific & Industrial Research.The Useful Plants of India. (New Delhi: Publications & Information Directorate, 1986) 229.
Rao RN, Sakariah KK. Lipid-lowering and antiobesity effect of (—)-hydroxycitric acid. Nutrition Research 1988;8(2):209-212.
Sugden MC, et al. Brown-adipose-tissue lipogenesis in starvation effects of insulin and (—)hydroxycitrate. Bioscience Reports 1982;2(5):289-297.
Sullivan C, Triscari J. Metabolic regulation as a control for lipid disorders. I. Influence of (—)-hydroxycitrate on experimentally induced obesity in the rodent. Am J Clin Nutr. May 1977;30(5):767-76.
Clouatre Dallas L.
Dunn James M.
Ewing James F.
Fitzgerald Marc C.
Glykon Technologies Group, LLC
Morency Michel
Woodward Michael P.
LandOfFree
Method for stable and controlled delivery of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for stable and controlled delivery of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for stable and controlled delivery of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3786851